Blood pressure , pulse rate etc comparision between LMA Protector and Cuffed Endotracheal Tube during Laparoscopic Cholecystectomy under general anaesthesia.

Lma protector versus cuffed endotracheal tube: a comparative study of hemodynamic responses in patients undergoing laparoscopic cholecystectomy. - Nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/04/107807

Enrollment

Registered

2026-04-07

Start date

Unknown

Completion date

Unknown

Last updated

2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K801- Calculus of gallbladder with othercholecystitis

Interventions

Intervention1: LMA insertion: LMA inserted in patients undergoing laparoscopic cholecystectomy under general anaesthesia within 3 minutes of induction . Intervention2: Cuffed endotracheal tube inserti

Eligibility

Inclusion criteria

Inclusion criteria: 1. Adult patients aged 18 60 years. 2.ASA (American Society of Anesthesiologists) physical status I or II. 3.Scheduled for elective laparoscopic cholecystectomy under general anesthesia. 4.Patients providing informed written consent.

Exclusion criteria

Exclusion criteria: 1.Anticipated difficult airway or Mallampati grade III IV, limited mouth opening,restricted neck movement 2. BMI more than30 kg per m or obese patients 3.History of gastroesophageal reflux disease or increased risk of aspiration. 4.Significant cardiovascular, respiratory, hepatic, or renal disease. 5.Known allergy or hypersensitivity to any drug or material used in the study. 6. Pregnant or lactating women. 7. Patients refusing to participate in the study. 8.Lap cholecystectomy cases converted to Open cholecystectomy.

Design outcomes

Primary

Measure	Time frame
It is expected that the LMA Protector will produce significantly attenuated hemodynamic responses compared to the cuffed endotracheal tube during insertion and pneumoperitoneal phase, with comparable intraoperative stability.Timepoint: 30 minutes	—

Secondary

Measure	Time frame
Patients undergoing laparoscopic cholecystectomy withLMA protector will have fewer adverse airway related events like sore throat,hoarseness,airway trauma etcTimepoint: 1 hour	—

Countries

India

Contacts

Public ContactDe Dibyendu Garai

Ipgmer and sskm hospital, Kolkata

dibyendugarai.dg@gmail.com9433181485

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026